Mar 2010;21(1):45-49
To achieve the best outcomes, this may involve a combination of medicine, diet, exercise, and other lifestyle changes
Semaglutide is indicated for obesity and Type 2 diabetes, while Ozempic is only licensed for Type 2 diabetes. Ozempic has been well-known in Cyprus for years as it has been extensively used off-label for obesity. Wegovy is another commercial semaglutide preparation at a higher dose, which is licensed for both conditions (diabetes and obesity) but is not available in Cyprus
ABIC = Adjusted Bayesian Information Criterion
Indeed, in studies of GLP-1 drugs, those who used higher dosages were more likely to report gastrointestinal side effects
When to Seek Medical Advice About Heart Rate Changes Whilst most patients tolerate Ozempic well without significant cardiovascular concerns, certain symptoms warrant prompt medical evaluation